Breaking Barriers and Bridging Gaps: Global Strategies for Implementing Innovations for Alzheimer’s Timely & Accurate Diagnosis

The Spring Meeting of the DAC Healthcare System Preparedness Learning Laboratory, 18 June 2024                                                   

On June 18th, the Davos Alzheimer’s Collaborative (DAC) Healthcare System Preparedness Learning Laboratory convened 450+ stakeholders from 45 countries and 270+ organizations to explore the current landscape for clinical adoption of blood biomarkers, introduce DAC Healthcare System Preparedness’s (DAC-SP) newly launched Accurate Diagnosis (AccDx) program, and discuss ongoing collaborations with organizations around the world to speed and scale early detection and accurate diagnosis of Alzheimer’s disease and related dementias.

We are entering a new, critical period for the global response to Alzheimer’s disease with novel treatments and diagnostic tests poised to transform care. However, in order for patients, clinicians, and families to realize the benefits of these innovations, health systems, governments, and other stakeholders must prioritize implementation to speed clinical adoption and broaden access. 

After decades of effort, we are finally seeing vital new diagnostics and treatments poised to move from the lab to the clinic. Our challenge now is to accelerate this process, far faster than the typical 17-20 years for routine use of clinical innovations, while ensuring new tools are used appropriately for the millions of families affected by Alzheimer’s disease in every country and community around the world. 

DAC Healthcare System Preparedness Program will continue collaborating with our partners to advance these goals, share findings through our Learning Laboratory, and equip healthcare systems to implement adaptable, proven solutions. 

Click here to read DAC’s full Call to Action.

SPEAKERS

•Karen Blackmon
Imarisha Center for Healthy Brain Aging, Brain and Mind Institute
Aga Khan University

•Tim MacLeod
Davos Alzheimer’s Collaborative

•Jeff Burns
University of Kansas Alzheimer’s Disease Research Center

•Lefkos Middleton
School of Public Health, Imperial College, London

•Amy Deckert
Davos Alzheimer’s Collaborative

•Michelle Mielke
Wake Forest University School of Medicine

•Ishtar Govia
Amagi Health, Ltd.

•Suzanne Schindler
Washington University

•Atsushi Iwata
Tokyo Metropolitan Institute for Geriatrics and Gerontology

•George Vradenburg
Davos Alzheimer’s Collaborative